Actavis News
Most Popular Actavis Story
Teva, Actavis remain in contest for Ratiopharm
And then there were two: Teva Pharmaceutical Industries and Actavis Group are said to be the last two bidders standing for a final round in the battle for German generics maker Ratiopharm. Sources... Read more...
Latest Headlines
- March 9, 2010
- March 4, 2010
- March 3, 2010
- February 18, 2010
- February 17, 2010
- February 11, 2010
- February 3, 2010
- November 12, 2009
- October 2, 2009
- July 29, 2009
- April 17, 2009
- February 4, 2009
- January 9, 2009
- October 20, 2008
- October 17, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
